- Published at
- by seekingalpha.com
positive
positive
LENZ Therapeutics: Time For A Pause (NASDAQ:LENZ)
Lenz Therapeutics may be on the verge of FDA approval for a 'best of breed' solution for near vision loss. But the stock is trading at levels now exceeding most analyst price targets.